loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 211230 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 SOLRIAMFETOL HYDROCHLORIDE (2)

filter

01 AXSOME MALTA (2)

filter

01 TABLET;ORAL (2)

filter

01 EQ 150MG BASE (1)

02 EQ 75MG BASE (1)

filter

01 USA (2)

URL Supplier Web Content
TABLET;ORAL
EQ 75MG BASE
SUNOSI
USA
211230
2019-06-17
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET;ORAL
EQ 150MG BASE
SUNOSI
USA
211230
2019-06-17
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 211230

Looking for CTD TGA MCC DOSSIER APPLICATION 211230 2

19

Axsome Therapeutics, based in U.S.A, is a pharmaceutical company.

One of their notable products is SOLRIAMFETOL HYDROCHLORIDE, with a corresponding application number 211230 and regulatory information .

proudly manufactured in the

approval since 2019-06-17

Axsome Therapeutics's SUNOSI TABLET;ORAL, medication with EQ 75MG BASE of SOLRIAMFETOL HYDROCHLORIDE.

18

Axsome Therapeutics, based in U.S.A, is a pharmaceutical company.

One of their notable products is SOLRIAMFETOL HYDROCHLORIDE, with a corresponding application number 211230 and regulatory information .

proudly manufactured in the

approval since 2019-06-17

Axsome Therapeutics's SUNOSI TABLET;ORAL, medication with EQ 150MG BASE of SOLRIAMFETOL HYDROCHLORIDE.

Post Enquiry
POST ENQUIRY